As a precautionary measure, the Austrian authorities suspended vaccination with one batch of covid-19 vaccine from AstraZeneca. The reason is the death of one woman and the health problems of another. However, according to the authorities, the death is not directly related to vaccination.
The report on both cases was published by the Austrian Federal Office for Health Safety (BASG). “The office received two reports in connection with the vaccination of the same batch of AstraZeneca vaccine at the Zwettl district clinic,” the office said, according to Reuters.
One 49-year-old woman died of a severe blood clotting disorder, the 35-year-old woman had a pulmonary embolism and was currently recovering in hospital. “There is currently no evidence of a causal link to vaccination,” BASG said. The Swiss daily Niederoesterreichische Nachrichten and the Austrian news agency APA reported that both women were nurses working at a clinic in Zwettl.
However, BASG stated that a blood clotting disorder was not one of the known side effects of the vaccine. Thus, according to its statement, the Office is consistently continuing its investigation in order to completely rule out any possible connection. “As a precautionary measure, the remaining stocks of this batch of vaccine are no longer released or vaccinated,” he added.
The APA news agency quoted AstraZenec as saying that the company was in contact with the Austrian authorities and would fully support the investigation. She said the vaccine was approved by the European Medicines Agency and the World Health Organization on the basis of a global clinical program involving 23,000 participants, writes Reuters.
“All of these evaluations concluded that AstraZeneca COVID-19 19 was safe and effective,” the company was quoted as saying by APA. European Union regulators approved the product on 30 January, stating that it was effective and safe. Adverse reactions observed in the studies were mostly short-term and no blood clotting problems were reported.